Posts by Ellie Oglesby
Glenmark Drug Recall: Potassium Chloride Extended Release Capsules
On June 24, 2024, the FDA published a recall of certain batches of Glenmark Pharmaceuticals’ Potassium Chloride Extended Release Capsules because they failed to meet the required dissolution specifications. According to the FDA, due to this defect, the “capsules may cause high potassium levels, also known as hyperkalemia, which can result in irregular heart beat that…
Read MoreUnderstanding Class Action Lawsuits: What You Need to Know
If you’ve ever heard about class action lawsuits but weren’t quite sure what they entailed, you’re not alone. These legal actions can seem complex, but they play a crucial role in our justice system. At The Block Firm in Atlanta, we specialize in class action lawsuits, and we’re here to break down what they are,…
Read MoreVictory for Main Street Burger in Lease Renewal Dispute
The Block Firm is thrilled to announce a significant legal victory for our client, Main Street Burger, Inc., in their recent appellate case against the Estate of David W. Collier and associated parties. This decision marks a pivotal moment in a prolonged lease dispute involving the revitalization efforts of the Kennesaw Downtown Development Authority (KDDA)…
Read MoreBreckenridge Duloxetine Recall Expands—Now Approximately 70 Million Pills
As The Block Firm previously revealed, Breckenridge Pharmaceutical, Inc. has recalled at least 50 million tablets of Duloxetine due to the presence of nitrosamines, potent carcinogens, in excess of FDA levels. As a result, The Block Firm filed a class action on behalf of Duloxetine patients, seeking to hold Breckenridge accountable for selling adulterated drugs.…
Read MoreCourt Grants Final Approval to $46.5 Million Class Action Settlement
This month The Block Firm obtained final approval of a $46.5 million class action settlement, which will benefit over a million class members nationwide. The settlement, in the case of Faulkner v. Acella Pharmaceuticals (N.D. Ga.), resolves allegations that a drugmaker sold a defective thyroid medication on the basis of false advertising about the drug’s active ingredient.…
Read MoreThe Block Firm Files Class Action About Contaminated Drugs
This week The Block Firm, partnering with our good friends at Anderson & Shah, filed a class action (read complaint here) against the manufacturer of a generic form of Cymbalta (duloxetine). The defendant, Breckenridge Pharmaceutical, Inc., recalled more than 50 million pills because they were contaminated with nitrosamines. Nitrosamines are a known byproduct of unsafe…
Read MoreAttorney Max Marks Argues on behalf of Fitzgerald Fruit Farms in front of the Supreme Court of Georgia in Case Whitaker Farms LLC vs. Fitzgerald Farms LLC
On May 16, 2024 Max Marks argued on behalf of Fitzgerald Farms in front of the Supreme Court of Georgia, defending his victories at trial and before the court of appeals in Whitaker Farms, LLC vs. Fitzgerald Farms LLC, No. s23G1162. In that case, Max represents a family farmer whose crops were destroyed as a result of what two…
Read MoreFDA Recalls Duloxetine: The Block Firm continues to investigate
The U.S. Food and Drug Administration (FDA) has recently issued a recall for duloxetine, a medication commonly prescribed for depression and anxiety. If you or a loved one has been taking duloxetine, this news may be concerning. At The Block Firm, we understand the impact such recalls can have on your health and well-being. Our…
Read MoreThe Block Firm Investigates the Presence of Carcinogens in Duloxetine (Generic Cymbalta)
Millions of Americans take the drug duloxetine—a generic form of Cymbalta—for depression, pain, and anxiety. According to a recent FDA announcement, tens of millions of duloxetine tablets sold by Breckenridge Pharmaceutical, Inc. are being recalled because they are apparently contaminated with a carcinogen in the nitrosamine family. Drug regulators consider nitrosamines as “high potency mutagenic…
Read MoreThe Block Firm Investigates Unapproved Thyroid Drug, Adthyza
The Block Firm is investigating a new potential case regarding Adthyza, an unapproved thyroid drug manufactured by Azurity. At The Block Firm, we believe that patients are entitled to safe and effective medication. By refusing to seek FDA approval for Adthyza, Azurity refused to prove that this drug meets federal standards for safety, efficacy, and…
Read More